0.00Open0.00Pre Close0 Volume0 Open Interest34.00Strike Price0.00Turnover412.00%IV-96.65%PremiumDec 20, 2024Expiry Date16.71Intrinsic Value100Multiplier7DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8183Delta0.0270Gamma0.99Leverage Ratio-0.1810Theta-0.0050Rho-0.81Eff Leverage0.0063Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet